ESMO Breast Cancer 2023 Congress Coverage
T

ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib in Platinum-Treated Advanced TNBC

By ESMO Breast Cancer 2023 Congress Coverage FEATURING Tira Tan
May 24, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

18:15
Novartis Oncology

CDK4/6 Inhibitor in Postmenopausal Patients With HR+/HER2- mBC: Anal…

Feat. G. Hortobagyi

Featured Video

17:04
Novartis Oncology

Discussion on Overall Survival Data Across 3 Phase III Trials in HR+…

Feat. G. Hortobagyi

Related Content

AUTOPLAY
18:34
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Positive Advanced Breast Cancer: Case 3: Treatment …

Feat. J. Abraham, R. Finn, M. Dickler
11:40
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Postive Advanced Breast Cancer Case 4: Patient with…

Feat. J. Abraham, R. Finn, M. Dickler
16:44
Heather McArthur

Modern Immune Therapy Strategies for Triple-Negative Breast Cancer

17:54
Heather McArthur

Modern Immune Therapy in ER, HR+/HER2-, HER2+ Breast Cancer

19:23
Holy Cross 9th Annual Winter Oncology Symposium

Genetic Testing in Breast and Ovarian Cancer: BRCA1/2 and PARP Inhib…

Feat. D. Guaqueta
07:43
Dana-Farber Cancer Institute

Study of Abemaciclib for Patients with RB-Positive, Triple Negative …

Feat. S. Goel
10:12
Holy Cross 9th Annual Winter Oncology Symposium

Emerging Targets in HER-2 Negative, TNBC and HER-3 Positive Breast C…

Feat. M. Abu-Khalaf
11:07
Baltic and Eurasia Masterclass in Clinical Oncology

Advanced Breast Cancer: Endocrine Therapy as Preferred Option for HR…

Feat. O. Pagani
10:53
Baltic and Eurasia Masterclass in Clinical Oncology

Neoadjuvant Systemic Therapy for HER2 + Early Breast Cancer - Review…

Feat. A. Česas
13:21
12th ESO-EONS Masterclass in Oncology Nursing

Neo-Adjuvant Therapy: For Who is Indicated? (Nurses)

Feat. O. Pagani
07:58
12th ESO-EONS Masterclass in Oncology Nursing

Triple Negative Disease: Adjuvant Therapy, Hormone Receptor + Diseas…

Feat. O. Pagani
13:36
Baltic and Eurasia Masterclass in Clinical Oncology

Systemic Treatment of TNBC: Staging, BRCAness, Chemotherapy Prognost…

Feat. E. Kharchenko
27:16
Baltic and Eurasia Masterclass in Clinical Oncology

Advanced Breast Cancer: Sequential Single-Agent Chemotherapy, Gradin…

Feat. E. Senkus
51:39
Yale Cancer Center

Review of Ongoing Trial on Olaparib With or Without Atezolizumab in …

Feat. P. LoRusso
16:29
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

NCCN Guidelines Update for ER+ Breast Cancer: CDK4/6 and PIK3CA Inhi…

Feat. J. Abraham, W. Gradishar
10:06
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

NCCN Guidelines Update for TNBC and HER2 Breast Cancer: Immunotherap…

Feat. J. Abraham, W. Gradishar
08:27
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Therapeutic Options for Systemic Treatment of TNBC & New Data on…

Feat. D. Hicks
15:23
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Q&A on Clinical Data Behind Changing the Guidelines, Her2+ Testi…

Feat. D. Hicks
18:38
Peter Schmid

Immunotherapy in Metastatic Triple Negative Breast Cancer: IMpassion…

07:23
Dana-Farber Cancer Institute

Study of Ribociclib and PDR001 in HR+ Metastatic Breast Cancer

Feat. S. Tolaney